Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Mads Gyrd-Hansen, from the Ludwig Institute for Cancer Research at the University of Oxford has received a prestigious Sapere Aude DFF-Starting Grant from the Danish Council for Independent Research, to investigate the role of ubiquitin in controlling innate immune signalling and inflammation.

Mads Gyrd-HansenThe objective of the Sapere Aude Starting Grant is to give the very best researchers who have achieved outstanding results in their field an opportunity to develop and strengthen their research ideas. 

Dr Gyrd-Hansen said: “I am honoured to have received such a prestigious grant. It will enable me to initiate a long-term and ambitious project to answer key questions about how communication in the immune system works.”

Dr Gyrd-Hansen attended an awards ceremony for the grant in Denmark on 6th February 2014 was awarded his diploma by the Danish Minister for Higher Education and Science.


Mads Gyrd-HansenImages:

Left: Dr Gyrd-Hansen with his diploma

Right: Dr Gyrd-Hansen front row, 2nd on the right, next to the Head of the Board of Directors and the Danish Minister for Higher Education and Science, front row, 4th on the left

Links:
Dr Mads Gyrd-Hansen webpage

Ludwig Institute for Cancer Research

Sapere Aude DFF-Starting Grant

Similar stories

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Professor Trish Greenhalgh Highly Commended in the O²RB Excellence in Impact Awards 2021

Congratulations to Professor Trish Greenhalgh (Nuffield Department of Primary Care Health Sciences) who has been Highly Commended in the O²RB Excellence in Impact Awards 2021.

Turing Fellowships for over 30 Oxford academics

Thirty-three University of Oxford researchers have been named Turing Fellows for the 2021/22 academic year, including eight from the Medical Sciences Division.

RECOVERY Trial paper wins BMJ’s 2021 UK Research Paper of the Year Award

For the second year in a row, The British Medical Journal have selected a publication co-authored by Oxford University researchers for their prestigious UK Research Paper of the Year Award. This award recognises original UK research that has the potential to contribute significantly to improving health and healthcare.

Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness

Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.